Heterologous Production of the C33-C45 Polyketide Fragment of Anticancer Apratoxins in a Cyanobacterial Host.

Org Lett

Department of Medicinal Chemistry and Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, Gainesville, Florida 32610, United States.

Published: April 2023

A polyketide synthase subcluster of cytotoxic apratoxin A was isolated from a environmental DNA library and engineered with a thioesterase II domain for heterologous expression in the filamentous cyanobacterium sp. PCC7120. Further engineering with a rhamnose-inducible promoter led to the production of (2,3,5,7)-3,7-dihydroxy-2,5,8,8-tetramethylnonanoic acid, a stereogenically rich chiral building block that is important to the efficient synthesis of apratoxin analogues, representing the first synthetic biology attempt for this type of polyketide fragment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198461PMC
http://dx.doi.org/10.1021/acs.orglett.3c00462DOI Listing

Publication Analysis

Top Keywords

polyketide fragment
8
heterologous production
4
production c33-c45
4
c33-c45 polyketide
4
fragment anticancer
4
anticancer apratoxins
4
apratoxins cyanobacterial
4
cyanobacterial host
4
host polyketide
4
polyketide synthase
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!